Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial.

Epilepsia · 2022 · PMC9544893 · PMID 35364618

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

In our small patient cohort of children with drug‐resistant epilepsy and MECP2 ‐related RTT, CBDV treatment was well tolerated, and an overall trend toward reduction in mean monthly seizure frequency was observed.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.